OCUGEN, INC. Increase (Decrease) in Accrued Liabilities
OCUGEN, INC. (OCGN) reported Increase (Decrease) in Accrued Liabilities of -$747.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2019-08-09
- OCUGEN, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-06-30 was $154.00K, a 71.38% decline year-over-year.
- OCUGEN, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-03-31 was -$901.00K.
- OCUGEN, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-12-31 was -$973.00K, a 188.29% decline year-over-year.
- OCUGEN, INC. increase (decrease) in accrued liabilities for the quarter ending 2018-09-30 was $339.00K, a 171.20% increase year-over-year.
- OCUGEN, INC. increase (decrease) in accrued liabilities for fiscal 2018 was -$1.71M, a 425.38% decline from fiscal 2017.
- OCUGEN, INC. increase (decrease) in accrued liabilities for fiscal 2017 was $524.00K, a 19.75% decline from fiscal 2016.
- OCUGEN, INC. increase (decrease) in accrued liabilities for fiscal 2016 was $653.00K.
- OCUGEN, INC. increase (decrease) in accrued liabilities for fiscal 2015 was -$232.00K, a 135.80% decline from fiscal 2014.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2019-06-30 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$747.00K 10-Q · filed 2019-08-09 | -$1.72M derived: sum of 3 quarters · filed 2019-08-09 | -$1.38M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2019-03-31 | -$901.00K 10-Q · filed 2019-05-15 | -$1.87M derived: sum of 2 quarters · filed 2019-05-15 | -$1.53M derived: sum of 3 quarters · filed 2019-05-15 | -$997.00K derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-12-31 | -$973.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$634.00K derived: sum of 2 quarters · filed 2019-03-22 | -$96.00K derived: sum of 3 quarters · filed 2019-08-09 | -$1.71M 10-K · filed 2019-03-22 | |||
| 2018-09-30 | $339.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $877.00K derived: sum of 2 quarters · filed 2019-08-09 | -$732.00K 10-Q · filed 2018-11-08 | $370.00K derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-06-30 | $538.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$1.07M 10-Q · filed 2019-08-09 | $31.00K derived: sum of 3 quarters · filed 2019-08-09 | $156.00K derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | -$1.61M 10-Q · filed 2019-05-15 | -$507.00K derived: sum of 2 quarters · filed 2019-05-15 | -$382.00K derived: sum of 3 quarters · filed 2019-05-15 | $18.00K derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $1.23M derived: sum of 2 quarters · filed 2019-03-22 | $1.63M derived: sum of 3 quarters · filed 2019-03-22 | $524.00K 10-K · filed 2019-03-22 | |||
| 2017-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $525.00K derived: sum of 2 quarters · filed 2018-11-08 | -$578.00K 10-Q · filed 2018-11-08 | $35.00K derived: sum of 4 quarters · filed 2018-11-08 | |||
| 2017-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$703.00K 10-Q · filed 2018-08-09 | -$90.00K derived: sum of 3 quarters · filed 2018-08-09 | $120.00K derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | -$1.10M 10-Q · filed 2018-05-10 | -$490.00K derived: sum of 2 quarters · filed 2018-05-10 | -$280.00K derived: sum of 3 quarters · filed 2018-05-10 | $13.00K derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $823.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.12M derived: sum of 3 quarters · filed 2018-03-15 | $653.00K 10-K · filed 2018-03-15 | |||
| 2016-09-30 | $210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $503.00K derived: sum of 2 quarters · filed 2017-11-09 | $40.00K 10-Q · filed 2017-11-09 | $1.35M derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2016-06-30 | $293.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$170.00K 10-Q · filed 2017-08-10 | $1.14M derived: sum of 3 quarters · filed 2017-08-10 | $622.00K derived: sum of 4 quarters · filed 2017-08-10 | |||
| 2016-03-31 | -$463.00K 10-Q · filed 2017-05-11 | $850.00K derived: sum of 2 quarters · filed 2017-05-11 | $329.00K derived: sum of 3 quarters · filed 2017-05-11 | -$591.00K derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $792.00K derived: sum of 2 quarters · filed 2017-03-16 | -$128.00K derived: sum of 3 quarters · filed 2017-03-16 | -$232.00K 10-K · filed 2017-03-16 | |||
| 2015-09-30 | -$521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$1.44M derived: sum of 2 quarters · filed 2016-11-10 | -$1.54M 10-Q · filed 2016-11-10 | $766.00K 10-Q · filed 2015-11-12 | -$1.49M derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | -$920.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$1.02M 10-Q · filed 2016-08-11 | $410.00K 10-Q · filed 2015-08-12 | -$970.00K derived: sum of 3 quarters · filed 2016-08-11 | -$1.02M derived: sum of 4 quarters · filed 2016-08-11 | ||
| 2015-03-31 | -$104.00K 10-Q · filed 2016-05-12 | $213.00K 10-Q · filed 2015-05-14 | -$50.00K derived: sum of 2 quarters · filed 2016-05-12 | -$97.00K derived: sum of 3 quarters · filed 2016-05-12 | $782.00K derived: sum of 4 quarters · filed 2016-05-12 | ||
| 2014-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $7.00K derived: sum of 2 quarters · filed 2016-03-10 | $886.00K derived: sum of 3 quarters · filed 2016-03-10 | $648.00K 10-K · filed 2016-03-10 | |||
| 2014-09-30 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $832.00K derived: sum of 2 quarters · filed 2015-11-12 | $594.00K 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | $879.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $641.00K 10-Q · filed 2015-08-12 | |||||
| 2014-03-31 | -$238.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |